September 2006 - IOZK

Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy

2006-09-27/in Glioblastoma, International Publications /von 2006-09-27 / J. Neurooncol. 2007 Jan;81(2):139-48

Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB „bulky“

2006-09-18/in Cervical Cancer, International Publications /von 2006-09-18 / Int. J. Radiat. Oncol. Biol. Phys. 2006 Nov;66(4):1159-67

Noninvasive magnetic resonance thermography of soft tissue sarcomas during regional hyperthermia: correlation with response and direct thermometry

2006-09-15/in Hyperthermia, International Publications, Soft Tissue Sarcoma /von 2006-09-15 / Cancer 2006 Sep;107(6):1373-82

Patient-specific dendritic-cell vaccines for metastatic melanoma

2006-09-14/in International Publications, Malignant Melanoma /von 2006-09-14 / N. Engl. J. Med. 2006 Sep;355(11):1179-81

Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma

2006-09-05/in Dendritic Cells, International Publications, Thyroid Cancer /von 2006-09-05 / J. Clin. Endocrinol. Metab. 2006 Nov;91(11):4571-7

Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers

2006-09-01/in Dendritic Cells, International Publications, Thyroid Cancer /von 2006-09-01 / Endocr. Relat. Cancer 2006 Sep;13(3):779-95

[Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma]

2006-09-01/in International Publications, Pancreatic Cancer /von 2006-09-01 / Ai Zheng 2006 Sep;25(9):1082-6

Basic overview of current immunotherapy approaches in urologic malignancy

2006-09-01/in International Publications, Prostate Cancer /von 2006-09-01 / Urol. Oncol. 2006 Sep-Oct;24(5):413-8

Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting cells

2006-09-01/in International Publications, Prostate Cancer /von 2006-09-01 / Urol. Oncol. 2006 Sep-Oct;24(5):434-41

Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity

2006-09-01/in International Publications, Malignant Melanoma /von 2006-09-01 / J. Immunother. 2006 Sep-Oct;29(5):545-57